Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of baloxavir marboxil plus neuraminidase inhibitor standard care in hospitalized patients with severe influenza
MOH_2018-10-10_003689Phase 3Not yet recruiting
- Sponsor
- Roche
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing baloxavir marboxil + standard of care with matching placebo + standard of care (2 arms). Planned start Sep 2018; status: not yet recruiting.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on MOH_2018-10-10_003689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-10-10_003689.